Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Psyence Biomedical Ltd (PBM)

Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,327
  • Shares Outstanding, K 63,380
  • Annual Sales, $ 0 K
  • Annual Income, $ -51,160 K
  • EBIT $ 0 M
  • EBITDA $ -3 M
  • 60-Month Beta -0.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on 01/31/24
  • Next Earnings Date 05/04/16
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0480 +9.37%
on 11/19/24
0.1380 -61.96%
on 10/22/24
-0.0555 (-51.39%)
since 10/18/24
3-Month
0.0480 +9.37%
on 11/19/24
0.5551 -90.54%
on 08/21/24
-0.4891 (-90.31%)
since 08/19/24

Most Recent Stories

More News
Psyence Biomedical Ltd. Announces Share Consolidation Effective November 26, 2024

Psyence Biomedical Ltd. announced a 1-for-75 share consolidation effective November 26 to comply with Nasdaq listing requirements.Quiver AI SummaryPsyence Biomedical Ltd. announced the effective date of...

PBM : 0.0525 (-2.60%)
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation

PBM : 0.0525 (-2.60%)
Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq

PBM : 0.0525 (-2.60%)
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs

PBM : 0.0525 (-2.60%)
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care

PBM : 0.0525 (-2.60%)
Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development

PBM : 0.0525 (-2.60%)
Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant

PBM : 0.0525 (-2.60%)
Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development

Vancouver, British Columbia and New York, New York--(Newsfile Corp. - August 13, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi"), a GMP-approved, Health Canada licensed psychedelics...

PBM : 0.0525 (-2.60%)
OPTHF : 0.1422 (+1.57%)
OPTI.CN : 0.2050 (+2.50%)

Business Summary

Psyence Biomed is a life science biotechnology company which focus on natural psychedelics. The company's operating divisions include Psyence Production, Psyence Therapeutics and Psyence Function which operates in Canada, the United Kingdom, Southern Africa, Australia and a presence in the United States....

See More

Key Turning Points

3rd Resistance Point 0.0677
2nd Resistance Point 0.0628
1st Resistance Point 0.0577
Last Price 0.0525
1st Support Level 0.0477
2nd Support Level 0.0428
3rd Support Level 0.0377

See More

52-Week High 4.3100
Fibonacci 61.8% 2.6819
Fibonacci 50% 2.1790
Fibonacci 38.2% 1.6761
Last Price 0.0525
52-Week Low 0.0480

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar